These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Clinical efficacy of ketolides in the treatment of respiratory tract infections. Reinert RR J Antimicrob Chemother; 2004 Jun; 53(6):918-27. PubMed ID: 15117934 [TBL] [Abstract][Full Text] [Related]
25. Telithromycin in the treatment of pneumococcal community-acquired respiratory tract infections: a review. Fogarty CM; Buchanan P; Aubier M; Baz M; van Rensburg D; Rangaraju M; Nusrat R Int J Infect Dis; 2006 Mar; 10(2):136-47. PubMed ID: 16183318 [TBL] [Abstract][Full Text] [Related]
26. PROTEKT years 1-3 (1999-2002): study design and methodology. Harding I; Felmingham D J Chemother; 2004 Dec; 16 Suppl 6():9-18. PubMed ID: 15690682 [No Abstract] [Full Text] [Related]
27. The evolution of antimicrobial agents used for the management of CARTIs: a focus on a new class of antimicrobials--the ketolides. Sbarbaro JA Am J Manag Care; 2004 Oct; 10(12 Suppl):S389-99. PubMed ID: 15603248 [No Abstract] [Full Text] [Related]
28. Introduction to PROTEkT: years 1-3 (1999-2002). Harding I J Chemother; 2004 Dec; 16 Suppl 6():5-7. PubMed ID: 15690681 [No Abstract] [Full Text] [Related]
29. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the Ketolide Telithromycin: results from the PROTEKT surveillance study (1999-2000). Reinert RR; Rodloff AC; Halle E; Baer W; Beyreiss B; Seifert H; Wichelhaus TA; Maass M; Mehl M Chemotherapy; 2004 Jun; 50(3):143-51. PubMed ID: 15272227 [TBL] [Abstract][Full Text] [Related]
30. Telithromycin--a ketolide antibiotic for the treatment of outpatients with community-acquired respiratory tract infections. Counts M Clin Nurse Spec; 2005; 19(3):121-3. PubMed ID: 15897765 [No Abstract] [Full Text] [Related]
31. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia. Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191 [TBL] [Abstract][Full Text] [Related]
32. Clinical efficacy of new antibacterial therapies in at-risk populations. Lorenz J J Infect; 2002 Feb; 44 Suppl A():25-30. PubMed ID: 12150492 [TBL] [Abstract][Full Text] [Related]